Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on March 6, 2008

Stroke. 2008
Published online before print March 6, 2008, doi: 10.1161/STROKEAHA.107.500363
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/4/1399    most recent
STROKEAHA.107.500363v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Aguilar, M. I.
Right arrow Articles by Hart, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguilar, M. I.
Right arrow Articles by Hart, R.
Related Collections
Right arrow Anticoagulants
Right arrow Antiplatelets
Right arrow Coumarins
Right arrow Other anticoagulants
Right arrow Platelet function inhibitors
Right arrow Primary prevention
Right arrow Embolic stroke

Submitted on July 30, 2007
Accepted on August 9, 2007

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks

Maria I. Aguilar MD* and Robert Hart MD

From the Mayo Clinic Arizona (M.I.A.), Phoenix, Ariz; University of Texas Health Science Center (R.G.H.), San Antonio, Tex.

* To whom correspondence should be addressed. E-mail: aguilar.maria{at}mayo.edu.


Key words: anticoagulant • antiplatelet • aspirin • atrial fibrillation • stroke • warfarin